MedTrace Logo

Billroth II With Braun Anastomosis After Radical Distal Gastrectomy for Gastric Cancer

NCT06229197 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 176

Last updated 2024-01-29

No results posted yet for this study

Summary

The primary aim of this trial is to rigorously evaluate the comparative benefits and potential risks associated with Billroth II reconstruction with Braun anastomosis versus Billroth II reconstruction alone following distal gastrectomy with D2 lymphadenectomy in patients diagnosed with gastric cancer. This assessment focuses on delineating the therapeutic efficacy, safety profile, and overall clinical outcomes of these two surgical approaches in treating this condition.

Conditions

Interventions

PROCEDURE

Billroth II reconstruction

Billroth II reconstruction, in which a loop of jejunum is mobilized and anastomosed to the gastric remnant

PROCEDURE

Braun Anastomosis

This is an additional surgical connection (anastomosis) created between two parts of the small intestine, specifically between the afferent (incoming) and efferent (outgoing) limbs of the jejunum near the gastrojejunostomy (the new connection between the stomach and small intestine created during a Billroth II procedure).

Sponsors & Collaborators

  • Sichuan University

    lead OTHER

Principal Investigators

  • Bo Zhang, MD · Gastric Cancer Center, Department of General Surgery, West China Hospital, Sichuan University

  • Zhaolun Cai, MD, PhD · Gastric Cancer Center, Department of General Surgery, West China Hospital, Sichuan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-01
Primary Completion
2026-12-31
Completion
2027-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06229197 on ClinicalTrials.gov